Sanjiv K. Patel 

Biography

  Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel joins the team having spent 10 years with Allergan, in roles of increasing responsibility. He began his career at Allergan, working as a Senior Director of Medical Aesthetics Business Unit before rising to his last role as Executive Vice President and Chief Strategy Officer.

Research Interest

  Relay Therapeutics is a relatively young biotech that focuses on discovering and developing medicines through its work on ‘protein motion’. In particular, this means using a drug discovery engine that can identify structural changes of proteins and how this regulates function – potentially providing it with drug targets. The company was launched from financing by Third Rock ventures, with a sum of $57 million.